CHEYENNE, Wyo., Feb. 27, 2024 /PRNewswire/ -- PCRS Network LLC, a leader in clinical research solutions, is proud to announce the launch of Feasibility PRO™, a cutting-edge platform designed to revolutionize clinical trial protocol development, site feasibility, and patient recruitment. By leveraging the latest in OpenAI technology, Feasibility PRO™ significantly streamlines the clinical research process..

怀俄明州夏延（CHEYENNE，Wyo.），2024年2月27日/PRNewswire/--临床研究解决方案的领导者PCRS Network LLC骄傲地宣布推出Expasibility PRO™，这是一个前沿平台，旨在彻底改变临床试验方案开发，现场可行性和患者招募。通过利用最新的OpenAI技术，可行性PRO™大大简化了临床研究过程。。

Feasibility PRO™ allows clinical research sites, referring physicians, and medical facilities to quickly identify potential trial participants by efficiently matching patients with the inclusion and exclusion criteria and any other protocol or patient criteria in less than 5 minutes; user consensus is less than 2 minutes! Its versatile, system-agnostic architecture ensures seamless operation without the need for integration, making it accessible to a broad range of users..

可行性PRO™通过在不到5分钟的时间内将患者与纳入和排除标准以及任何其他方案或患者标准有效匹配，使临床研究站点，转诊医生和医疗机构能够快速识别潜在的试验参与者；用户共识不到2分钟！其多功能、系统无关的体系结构确保了无缝操作，无需集成，使其可供广大用户使用。。

The platform empowers sponsors and CROs to design protocols that are more enrollable and to identify the most suitable clinical research sites using transparent, de-identified patient data. Feasibility PRO™ is designed to be user-friendly, enabling users without technical or clinical research backgrounds to perform secure queries, safeguarding patient identifiable information.

该平台使赞助商和CRO能够设计更具可注册性的协议，并使用透明的，未识别的患者数据确定最合适的临床研究地点。可行性PRO™设计为用户友好型，使没有技术或临床研究背景的用户能够执行安全查询，保护患者的可识别信息。

Utilizing advanced artificial intelligence, it processes medical records databases, automatically generating de-identified output that enhances the feasibility process's accuracy and transparency. Modify your protocol details 'on the fly' and test the change against a patient database in seconds!.

它利用先进的人工智能处理病历数据库，自动生成不确定的输出，从而提高可行性过程的准确性和透明度。“即时”修改您的协议详细信息，并在几秒钟内针对患者数据库测试更改！。

Gary Fiocco, CEO of PCRS Network LLC, states, 'Feasibility PRO™ supports our mission to Save and Improve Lives by Accelerating Clinical Research. By integrating OpenAI's innovative technology with our expertise, we address key industry challenges, particularly in improving the efficiency of patient recruitment.'.

PCRS Network LLC首席执行官加里·菲奥科（GaryFiocco）表示，“Probability PRO™支持我们通过加速临床研究来挽救和改善生命的使命。通过将OpenAI的创新技术与我们的专业知识相结合，我们解决了关键的行业挑战，特别是在提高患者招募效率方面。”。

Patient recruitment is a critical challenge in clinical trials, with many failing to meet enrollment targets, causing delays and increased costs. Furthermore, the need for trials to include a diverse participant pool is more pressing than ever. Feasibility PRO™ directly addresses these challenges, leveraging digital technology to improve trial processes and reach a wider, more diverse patient population, ensuring more inclusive and effective trials..

患者招募是临床试验中的一个关键挑战，许多患者未能达到入选目标，导致延误和成本增加。此外，试验需要包括一个多样化的参与者库，这比以往任何时候都更加迫切。Probability PRO™直接解决了这些挑战，利用数字技术改进了试验流程，并覆盖了更广泛、更多样化的患者群体，确保了更具包容性和有效的试验。。

PCRS Network LLC continues to lead in driving innovation in clinical research, enhancing the experiences of researchers, participants, and the broader healthcare community.

PCS Network LLC继续在推动临床研究创新方面发挥领导作用，提高研究人员、参与者和更广泛的医疗保健界的经验。

About PCRS Network LLC:PCRS Network LLC is at the forefront of clinical research, offering sophisticated solutions for trial management, patient recruitment, data analysis, and support services to sites, sponsors, and CROs.

关于PCRS Network LLC：PCRS Network LLC处于临床研究的前沿，为网站，赞助商和CRO提供试验管理，患者招募，数据分析和支持服务的复杂解决方案。

Contact:Gary Fiocco, CEOPCRS Network, LLC[email protected]

联系人：Gary Fiocco，CEOPCRS Network，LLC[受电子邮件保护]

Website:https://www.pcrsnetwork.com/feasibility-pro/

网站https://www.pcrsnetwork.com/feasibility-pro/

SOURCE PCRS Network LLC

SOURCE PCRS Network LLC公司